Intercept Pharmaceuticals Inc RSI
Что обозначает RSI в Intercept Pharmaceuticals Inc?
RSI Intercept Pharmaceuticals Inc является 75.79
Какое определение для RSI?
Индекс относительной силы (RSI 14) - это индикатор импульса, который сравнивает величину прибылей и убытков за определенный период времени для измерения скорости и изменения движений цены ценных бумаг.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI компаний в Health Care сектор на NASDAQ по сравнению с Intercept Pharmaceuticals Inc
Что делает Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Компании с rsi похож на Intercept Pharmaceuticals Inc
- Kaleyra Inc имеет RSI из 75.76
- Majesco имеет RSI из 75.76
- Mesabi Trust имеет RSI из 75.76
- Danone SA имеет RSI из 75.77
- Thangamayil Jewellery имеет RSI из 75.77
- Starlight U.S. Multi-Family (No. 1) Core Plus Fund имеет RSI из 75.78
- Intercept Pharmaceuticals Inc имеет RSI из 75.79
- 5N Plus имеет RSI из 75.81
- SenSen Networks имеет RSI из 75.82
- Jindal Saw имеет RSI из 75.82
- Goodluck India имеет RSI из 75.82
- Kerry Plc имеет RSI из 75.83
- Nuvo Pharmaceuticals имеет RSI из 75.84